High-Concentration 7-Hydroxymitragynine Inhalation for Rapid Onset

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current inhalation-based delivery devices for 7-hydroxymitragynine provide low-concentration solutions, limiting the onset rate and dosage of the compound, which are not sufficient for rapid therapeutic effects.

Innovation Solution

Development of compositions comprising high concentrations of 7-hydroxymitragynine and/or mitragynine pseudoindoxyl, administered through vaporizing or aerosolizing devices, allowing for rapid onset and higher total doses.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If low-concentration 7-hydroxymitragynine solutions are used in inhalation devices, then the device complexity is reduced and ease of manufacture is improved, but the dosage and onset rate are limited

Engineering Contradiction:

Improve7-hydroxymitragynine dosageVSAvoidinhalation device complexity

Core Design Contradiction:

Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent changes the concentration parameter of 7-hydroxymitragynine from low (existing devices) to high (at least 10% by weight), directly increasing the dosage delivered per inhalation while maintaining device simplicity

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent performs preliminary isolation and concentration of 7-hydroxymitragynine from kratom leaf material before device formulation, creating a high-concentration composition that can be delivered efficiently through simple inhalation devices without requiring complex delivery mechanisms

Inventive Principle:

Principle #10Preliminary action

2Speed

If oral administration of capsuled powders is used, then the device complexity is minimized, but the onset rate is slow

Engineering Contradiction:

Improveonset rateVSAvoidadministration device complexity

Core Design Contradiction:

SpeedVSDevice complexity

Solution Approach 1:

The patent employs inhalation (a pneumatic/rrespiratory-based delivery system) to administer the high-concentration 7-hydroxymitragynine composition, enabling rapid absorption through the lungs and achieving fast onset rates without requiring complex injection or infusion devices

Inventive Principle:

Principle #29Pneumatics and hydraulics

Solution Approach 2:

The patent changes the administration route from oral (slow absorption) to inhalation (rapid absorption), significantly increasing the onset rate while keeping the device simple and the composition form straightforward

Inventive Principle:

Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The high-concentration compositions provide rapid therapeutic effects and longer duration by achieving quick drug concentrations and prompt physiological responses.

Implementation Method 1

volatilizing the composition within the device, and inhaling the volatilized composition

Methodology Applied

Scientific EffectVaporization: Evaporation

Data Source

PatentUS20260021081A1Inhalation device for 7-oh-mitragynine

Publication Date: 2026.01.22 SUNFLOWER WELLNESS INC

AI summary

Compositions comprising at least 10% of a compound of formula (I) by weight, at least 10% of a compound of formula (II) by weight, or at least 10% by weight of a combination of a compound of formula (I) and a compound of formula (II), are disclosed herein. Methods for administering the compositions are disclosed herein. The methods can be used to produce a calming effect, produce an analgesic effect, manage pain, treat cough, treat anxiety, treat depression, treat opioid use disorder, and/or to treat opioid withdrawal in a subject.